172 related articles for article (PubMed ID: 38197430)
21. Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells.
Ketola K; Kallioniemi O; Iljin K
PLoS One; 2012; 7(12):e51470. PubMed ID: 23251544
[TBL] [Abstract][Full Text] [Related]
22. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.
Ward AB; Mir H; Kapur N; Gales DN; Carriere PP; Singh S
World J Surg Oncol; 2018 Jun; 16(1):108. PubMed ID: 29898731
[TBL] [Abstract][Full Text] [Related]
23. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
[TBL] [Abstract][Full Text] [Related]
24. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
Noble AR; Maitland NJ; Berney DM; Rumsby MG
Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
[TBL] [Abstract][Full Text] [Related]
25. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.
Singh RP; Agarwal R
Anticancer Res; 2005; 25(4):2891-903. PubMed ID: 16080543
[TBL] [Abstract][Full Text] [Related]
27. Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity.
Deep G; Kumar R; Jain AK; Dhar D; Panigrahi GK; Hussain A; Agarwal C; El-Elimat T; Sica VP; Oberlies NH; Agarwal R
Sci Rep; 2016 Mar; 6():23135. PubMed ID: 26979487
[TBL] [Abstract][Full Text] [Related]
28. HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.
He Z; Gao Y; Li T; Yu C; Ou L; Luo C
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35191516
[TBL] [Abstract][Full Text] [Related]
29. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
[TBL] [Abstract][Full Text] [Related]
30. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of natural bioactive compounds against prostate cancer: Molecular targets and synergistic activities.
Mia MAR; Dey D; Sakib MR; Biswas MY; Prottay AAS; Paul N; Rimti FH; Abdullah Y; Biswas P; Iftehimul M; Paul P; Sarkar C; El-Nashar HAS; El-Shazly M; Islam MT
Phytother Res; 2023 Dec; 37(12):5724-5754. PubMed ID: 37786304
[TBL] [Abstract][Full Text] [Related]
35. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway.
Wu HE; Su CC; Wang SC; Liu PL; Cheng WC; Yeh HC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Chen YR; Yu YH; Huang SP; Li CY
Am J Chin Med; 2023; 51(4):1019-1039. PubMed ID: 37120705
[TBL] [Abstract][Full Text] [Related]
36. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
Dong F; Yang P; Wang R; Sun W; Zhang Y; Wang A; Chen M; Chen L; Zhang C; Jiang M
Prostate; 2019 Aug; 79(11):1284-1293. PubMed ID: 31212374
[TBL] [Abstract][Full Text] [Related]
37. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
38. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
39. Combined CRISPRi and proteomics screening reveal a cohesin-CTCF-bound allele contributing to increased expression of RUVBL1 and prostate cancer progression.
Tian Y; Dong D; Wang Z; Wu L; Park JY; ; Wei GH; Wang L
Am J Hum Genet; 2023 Aug; 110(8):1289-1303. PubMed ID: 37541187
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
